The leadership team at Dewpoint Therapeutics has a strong history in the scientific and medical communities, with many members having worked at renowned institutions such as the Whitehead Institute, Dana-Farber Cancer Institute, and Brigham and Women's Hospital. The team also has significant experience in the financial sector, with members having served as Chief Financial Officer at companies such as Sema4, Spero Therapeutics, and Forward Pharma A/S. Additionally, the team has experience in human resources, with members having served as HR Executive Partner (VP), R&D and Legal at Alexion Pharmaceuticals, Inc. and Global HR (P&O) Head, NTO Cell & Gene Therapy and NTO Strategy at Novartis.
Ameet Nathwani
CEO
Anthony Hyman
Founder & Board Member
Aravind Subramanian
Head of Digital & Technology P...
Denise Schultz
Chief of Staff to the CEO
Elina Sinisalo
P&C Business Partner
Geoff Stamper
VP, New Product Strategy
Isaac Klein
Chief Scientific Officer
Kelly Clark
Head of Project & Portfolio Ma...
Lori Escobedo
Chief People Officer
Michael Fenn
Head of External Innovation
Richard Young
Founder & Board Member
View all